Evaluation and Optimization of the NCD Screening and Management Tool - A Three Arm Quasi- Experimental Study in selcted Talukas of Karnataka
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2021 - 2024
Project Lead
Dr. Tony D.S. Raj
Authors
Dr. Tony D.S. Raj
Project Status
completed
Project Type
Foreign